AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| (NASDAQ: ACIU) | Delayed: 2.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.47 | 52 Week High | $19.97 | |||
| Open | $2.47 | 52 Week Low | $10.36 | |||
| Day High | $2.47 | P/E | N/A | |||
| Day Low | $2.47 | EPS | $0.00 | |||
| Volume | 30 | |||||
